Study: ICU ECMO experience a factor in COVID-19 patient survivalAn analysis of extracorporeal membrane oxygenation (ECMO) use at 17 intensive care units (ICUs) in the greater Paris area during France's first COVID-19 wave reveal that 90-day survival was strongly linked to a hospital's earlier experience with the procedure.
Investigators from France detailed their findings yesterday in The Lancet Respiratory Medicine.During France's first surge, clinicians in Paris organized ECMO indications and pooled resources, which consisted of six mobile ECMO teams to cover the region.
For the study, the group looked at the outcomes of all 302 COVID-19 patients who received ECMO from Mar 8 through Jun 3, 2020, finding a survival rate of 46%.The most